Medtronic, Inc. Gets FDA Warning Letter On Pain Products

CHICAGO, Sept 12 (Reuters) - The U.S. Food and Drug Administration has warned Medtronic Inc. (MDT.N: Quote, Profile, Research) it found quality system violations during a facility inspection in Minneapolis, according to a posting Tuesday on the agency's web site.

>>> Discuss This Story

Back to news